Specialties
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Classics™
COVID Central
Rewinds
Click for the Rewinds Archive
Write for Us
Writer Application
Submit an Opinion
Subscribe
For Partners
License Content
Submit Press Release
Advertise with Us
Account
Register
Sign-In
Manage Subscriptions
Search
Wednesday, February 24, 2021
About
Masthead
License Content
Advertise
Submit Press Release
RSS/Email List
Write for us
Contact us
2 Minute Medicine
Specialties
All
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Azithromycin does not reduce mortality in patients hospitalized with COVID-19
Antibiotic prophylaxis for UTIs in elderly patients associated with an increased…
Limiting On-Call Hours Improves Resident-Physicians’ Neurobehavioral Performance
Early head-to-pelvis CT imaging for patients experiencing out-of-hospital circulatory arrest is…
Classics™
COVID Central
Rewinds
2 Minute Medicine Rewind February 22, 2021
2 Minute Medicine Rewind February 8, 2021
2 Minute Medicine Rewind Jan 25, 2021
2 Minute Medicine Rewind January 25, 2021
2 Minute Medicine Rewind January 18, 2021
Click for the Rewinds Archive
Write for Us
Writer Application
Submit an Opinion
Subscribe
For Partners
License Content
Submit Press Release
Advertise with Us
Account
Register
Sign-In
Manage Subscriptions
Tag: carfilzomib
#VisualAbstract Phase I: Adding carfilzomib to HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia showed favourable safety and efficacy outcomes
Kathleen Lau
-
February 19, 2021
0
Read more
#VisualAbstract Renal Toxicity Associated with Carfilzomib in Multiple Myeloma Patients
Kathleen Lau
-
December 3, 2020
0
Read more
